Press monitoring
Structure of enzyme offers treatment clues for diabetes, Alzheimer's
30.10.2006 | Press monitoring
Researchers from the University of Chicago and Argonne National Laboratory have deciphered the three-dimensional structure of insulin-degrading enzyme, a promising target for new drugs because it breaks down not only insulin but also the amyloid-beta protein, which has been linked to the cognitive decline of Alzheimer's disease.
New biochip could accelerate drug development
29.10.2006 | Press monitoring
Researchers have developed a biochip that could prove crucial in future drug development. The technology measures electrical activities of cells and can obtain 60 times more data in one reading than is possible with current technology.
Designer Babies: Ethical Considerations
28.10.2006 | Press monitoring
In 2004 the term “designer baby” made the transition from sci-fi movies and weblogs into the Oxford English Dictionary, where it is defined as “a baby whose genetic makeup has been artificially selected by genetic engineering combined with in vitro fertilization to ensure the presence or absence of particular genes or characteris...
Scientists discover toxin that causes gastro disease
27.10.2006 | Press monitoring
Australian scientists have identified a highly potent toxin that causes severe gastrointestinal illnesses, including food poisoning.
Study to genotype six common diseases
26.10.2006 | Press monitoring
WASHINGTON, Oct. 10 (UPI) -- Six common diseases have been selected as the first to undergo whole genome analysis by the U.S. Genetic Association Information Network.
The Human Genome Project
25.10.2006 | Press monitoring
The Human Genome Project: A Scientific and Ethical Overview By Marion L. Carroll and Jay Ciaffa
UCSD Developing New Genome Sequencing Technology
24.10.2006 | Press monitoring
The current cost to determine the sequence of nucleotide bases in the 6-billion-base-pair human genome is roughly $10 million, but researchers at UC San Diego and eight other universities and biotech companies hope to use a federal grant to lower the cost to only $1,000 per human genome sequenced.
What Are Stem Cells ?
23.10.2006 | Press monitoring
And Why Are They So Important For Parkinson's and Alzheimers Disease?
Biotech Research Helps Create Knowledge-based Economy
20.10.2006 | Press monitoring
Plant biotechnology is helping to create a vibrant knowledge-based economy throughout the United States, according to a study by a University of Minnesota professor.
Nuts’ New Aflatoxin Fighter: Caffeic Acid?
19.10.2006 | Press monitoring
Crunchy, good-for-you nuts like almonds, pistachios, and walnuts make their way to your local supermarket only after they’ve passed a rigorous safety test. The assay ensures that the nuts are free of unsafe levels of aflatoxin, a natural, cancer-causing compound.
